OMERS Administration Corp’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $446K | Hold |
3,547
| – | – | ﹤0.01% | 669 |
|
|
2025
Q1 | $392K | Sell |
3,547
-587
| -14% | -$64.9K | ﹤0.01% | 800 |
|
|
2024
Q4 | $564K | Buy |
4,134
+714
| +21% | +$97.5K | ﹤0.01% | 669 |
|
|
2024
Q3 | $394K | Sell |
3,420
-2,700
| -44% | -$311K | ﹤0.01% | 706 |
|
|
2024
Q2 | $843K | Buy |
+6,120
| New | +$843K | 0.01% | 571 |
|
|
2016
Q4 | – | Sell |
-118,300
| Closed | -$5.99M | – | 471 |
|
|
2016
Q3 | $5.99M | Buy |
118,300
+79,300
| +203% | +$4.02M | 0.11% | 131 |
|
|
2016
Q2 | $1.77M | Buy |
+39,000
| New | +$1.77M | 0.04% | 255 |
|